Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
probenecid pannexin-1 small molecule NA drugbank Mental concentration[MeSHID:D001288]
Serum[MeSHID:D044967]
Neoplasm Metastasis[MeSHID:D009362]
Arthritis
Gouty[MeSHID:D015210]
Gout[MeSHID:D006073]
Hyperuricemia[MeSHID:D033461]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational antagonist
probenecid solute carrier family 22 member 11 small molecule NA drugbank , DGIDB Mental concentration[MeSHID:D001288]
Serum[MeSHID:D044967]
Neoplasm Metastasis[MeSHID:D009362]
Arthritis
Gouty[MeSHID:D015210]
Gout[MeSHID:D006073]
Hyperuricemia[MeSHID:D033461]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 13.92 approved,investigational inhibitor
probenecid solute carrier family 22 member 6 small molecule NA drugbank , DGIDB Mental concentration[MeSHID:D001288]
Serum[MeSHID:D044967]
Neoplasm Metastasis[MeSHID:D009362]
Arthritis
Gouty[MeSHID:D015210]
Gout[MeSHID:D006073]
Hyperuricemia[MeSHID:D033461]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.96 approved,investigational inhibitor
probenecid solute carrier family 22 member 8 small molecule Successful target TTD , drugbank , DGIDB Mental concentration[MeSHID:D001288]
Serum[MeSHID:D044967]
Neoplasm Metastasis[MeSHID:D009362]
Arthritis
Gouty[MeSHID:D015210]
Gout[MeSHID:D006073]
Hyperuricemia[MeSHID:D033461]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 7.34 approved,investigational inhibitor
probenecid taste receptor type 2 member 16 small molecule NA drugbank Mental concentration[MeSHID:D001288]
Serum[MeSHID:D044967]
Neoplasm Metastasis[MeSHID:D009362]
Arthritis
Gouty[MeSHID:D015210]
Gout[MeSHID:D006073]
Hyperuricemia[MeSHID:D033461]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
click here to return to the previous page